Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Interferon-beta(1b) treatment in neuromyelitis optica.
Statement on a nonproprietary name adopted by the USAN Council
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Estrogen treatment in multiple sclerosis.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Monoclonal antibodies in MS: mechanisms of action.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
The challenge of comorbidity in clinical trials for multiple sclerosis.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Drugs@FDA (Enter "glatiramer acetate" in search box.)

Pages